Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2010, Article ID 517547, 8 pages
http://dx.doi.org/10.1155/2010/517547
Research Article

Decreased Expression of T-Cell Costimulatory Molecule CD28 on CD4 and CD8 T Cells of Mexican Patients with Pulmonary Tuberculosis

1Facultad de Farmacia, Universidad Autonoma del Estado de Morelos, 62209 Morelos, Mexico
2Departamento de Inmunologia, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Apartado Postal 70228 Ciudad Universitaria, 04510, Mexico City, Mexico

Received 25 January 2010; Revised 1 July 2010; Accepted 19 July 2010

Academic Editor: Robert S. Wallis

Copyright © 2010 German Bernal-Fernandez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Cooper, “Cell-mediated immune responses in tuberculosis,” Annual Review of Immunology, vol. 27, pp. 393–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. M. Woodworth and S. M. Behar, “Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity,” Critical Reviews in Immunology, vol. 26, no. 4, pp. 317–352, 2006. View at Google Scholar · View at Scopus
  3. M. Holden, M. R. Dubin, and P. H. Diamond, “Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis,” New England Journal of Medicine, vol. 285, no. 27, pp. 1506–1509, 1971. View at Google Scholar · View at Scopus
  4. J. C. Delgado, E. Y. Tsai, S. Thim et al., “Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7576–7581, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Pilheu, M. C. De Salvo, J. Gonzalez, D. Rey, M. C. Elias, and M. C. Ruppi, “CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection,” International Journal of Tuberculosis and Lung Disease, vol. 1, no. 5, pp. 422–426, 1997. View at Google Scholar · View at Scopus
  6. S. J. Kony, A. A. Hane, B. Larouzé et al., “Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar,” Journal of Infection, vol. 41, no. 2, pp. 167–171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Filipe-Santos, J. Bustamante, A. Chapgier et al., “Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features,” Seminars in Immunology, vol. 18, no. 6, pp. 347–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Caragol, M. Raspall, C. Fieschi et al., “Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor β1 deficiency,” Clinical Infectious Diseases, vol. 37, no. 2, pp. 302–306, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Lienhardt, A. Azzurri, A. Amedei et al., “Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo,” European Journal of Immunology, vol. 32, no. 6, pp. 1605–1613, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. C. S. Hirsch, Z. Toossi, J. L. Johnson et al., “Augmentation of apoptosis and interferon-γ production at sites of active Mycobacterium tuberculosis infection in human tuberculosis,” Journal of Infectious Diseases, vol. 183, no. 5, pp. 779–788, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. O. Sousa, J. I. Salem, F. K. Lee et al., “An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 24, pp. 13227–13232, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. P. M. Kaye, “Costimulation and the regulation of antimicrobial immunity,” Immunology Today, vol. 16, no. 9, pp. 423–427, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Henderson, S. C. Watkins, and J. L. Flynn, “Activation of human dendritic cells following infection with Mycobacterium tuberculosis,” Journal of Immunology, vol. 159, no. 2, pp. 635–643, 1997. View at Google Scholar · View at Scopus
  14. P. Rajavelu and S. D. Das, “Expression of co-stimulatory molecules B7.1 & B7.2 on macrophages infected with various strains of Mycobacterium tuberculosis & its influence on T-cell apoptosis,” Indian Journal of Medical Research, vol. 127, no. 4, pp. 388–394, 2008. View at Google Scholar · View at Scopus
  15. P. Soler, V. Boussaud, J. Moreau et al., “In situ expression of B7 and CD40 costimulatory molecules by normal human lung macrophages and epithelioid cells in tuberculoid granulomas,” Clinical and Experimental Immunology, vol. 116, no. 2, pp. 332–339, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ponticiello, F. Perna, M. C. J. M. Sturkenboom, I. Marchetiello, M. Bocchino, and A. Sanduzzi, “Demographic risk factors and lymphocyte populations in patients with tuberculosis and their healthy contacts,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 12, pp. 1148–1155, 2001. View at Google Scholar · View at Scopus
  17. K. Bhatt, A. Uzelac, S. Mathur, A. McBride, J. Potian, and P. Salgame, “B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 182, no. 6, pp. 3793–3800, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Thompson, J. R. Gralow, R. Levy, and R. A. Miller, “The optimal application of forward and ninety-degree light scatter in flow cytometry for the gating of mononuclear cells,” Cytometry, vol. 6, no. 5, pp. 401–406, 1985. View at Google Scholar · View at Scopus
  19. World Health Organization, “Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance,” WHO, Geneva, Switzerland, 2008, www.who.int/tb/publications/2008/drs_report4_26feb08.pdf.
  20. S. Rajagopalan, “Tuberculosis and aging: a global health problem,” Clinical Infectious Diseases, vol. 33, no. 7, pp. 1034–1039, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. Boletin de la Dirección General de Epidemiologia SSA, Mexico City, 1994.
  22. B. Grubeck-Loebenstein and G. Wick, “The aging of the immune system,” Advances in Immunology, vol. 80, pp. 243–284, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Bernal-Fernández, C. Hermida, P. Espinosa-Cueto et al., “Impact of opportunistic Mycobacterium tuberculosis infection on the phenotype of peripheral blood T cells of AIDS patients,” Journal of Clinical Laboratory Analysis, vol. 20, no. 3, pp. 80–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. S. S. Rodrigues, E. A. S. Medeiros, L. Y. Weckx, W. Bonnez, R. Salomão, and E. G. Kallas, “Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease,” Clinical and Experimental Immunology, vol. 128, no. 1, pp. 149–154, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. T. C. Y. Tsao, C.-H. Chen, J.-H. Hong, M.-J. Hsieh, K.-C. Tsao, and C.-H. Lee, “Shifts of T4/T8 T lymphocytes from bal fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis,” Chest, vol. 122, no. 4, pp. 1285–1291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Muller, S. P. Cobbold, H. Waldmann, and S. H. E. Kaufmann, “Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells,” Infection and Immunity, vol. 55, no. 9, pp. 2037–2041, 1987. View at Google Scholar · View at Scopus
  27. I. M. Orme and F. M. Collins, “Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients,” Journal of Experimental Medicine, vol. 158, no. 1, pp. 74–83, 1983. View at Google Scholar · View at Scopus
  28. A. N. Akbar and J. M. Fletcher, “Memory T cell homeostasis and senescence during aging,” Current Opinion in Immunology, vol. 17, no. 5, pp. 480–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Urdaneta, E. Feo-Figarella, C. Montalvo et al., “Characterization of local memory cells in stage-classified pulmonary tuberculosis: preliminary observations,” Scandinavian Journal of Immunology, vol. 47, no. 5, pp. 496–501, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Hertoghe, A. Wajja, L. Ntambi et al., “T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB),” Clinical and Experimental Immunology, vol. 122, no. 3, pp. 350–357, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. A. H. Sharpe and G. J. Freeman, “The B7-CD28 superfamily,” Nature Reviews Immunology, vol. 2, no. 2, pp. 116–126, 2002. View at Google Scholar · View at Scopus
  32. T. H. Watts, “TNF/TNFR family members in costimulation of T cell responses,” Annual Review of Immunology, vol. 23, pp. 23–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. E. Munk, P. Kern, and S. H. E. Kaufmann, “Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions,” International Immunology, vol. 9, no. 5, pp. 713–720, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Del Prete, M. De Carli, F. Almerigogna et al., “Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines,” FASEB Journal, vol. 9, no. 1, pp. 81–86, 1995. View at Google Scholar · View at Scopus
  35. J.-G. Chai, S. Vendetti, I. Bartok et al., “Critical role of costimulation in the activation of naive antigen- specific TCR transgenic CD8+ T cells in vitro,” Journal of Immunology, vol. 163, no. 3, pp. 1298–1305, 1999. View at Google Scholar · View at Scopus
  36. B. Wang, R. Maile, R. Greenwood, E. J. Collins, and J. A. Frelinger, “Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells,” Journal of Immunology, vol. 164, no. 3, pp. 1216–1222, 2000. View at Google Scholar · View at Scopus
  37. J. H. Vingerhoets, G. L. Vanham, L. L. Kestens et al., “Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects,” Clinical and Experimental Immunology, vol. 100, no. 3, pp. 425–433, 1995. View at Google Scholar · View at Scopus
  38. R. H. Schwartz, “T cell anergy,” Annual Review of Immunology, vol. 21, pp. 305–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Marks, M. Verolin, A. Stensson, and N. Lycke, “Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection,” Infection and Immunity, vol. 75, no. 9, pp. 4638–4647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-W. Mittrücker, A. Köhler, T. W. Mak, and S. H. E. Kaufmann, “Critical role of CD28 in protective immunity against Salmonella typhimurium,” Journal of Immunology, vol. 163, no. 12, pp. 6769–6776, 1999. View at Google Scholar · View at Scopus
  41. J. Murray, P. Sonnenberg, S. C. Shearer, and P. Godfrey-Faussett, “Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 3, pp. 733–740, 1999. View at Google Scholar · View at Scopus
  42. J.-S. Lee, C.-H. Song, C.-H. Kim et al., “Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients,” Medical Microbiology and Immunology, vol. 192, no. 2, pp. 61–69, 2003. View at Google Scholar